Management of Ductal Carcinoma In Situ
Management of Ductal Carcinoma In Situ 4 Susan B. Kesmodel, Natalie O’Neill, Steven J. Feigenberg, Alex Engelman, Katherine H. R. Tkaczuk, Susan Shyu, and Olga Ioffe INTRODUCTION Ductal carcinoma…
Management of Ductal Carcinoma In Situ 4 Susan B. Kesmodel, Natalie O’Neill, Steven J. Feigenberg, Alex Engelman, Katherine H. R. Tkaczuk, Susan Shyu, and Olga Ioffe INTRODUCTION Ductal carcinoma…
Breast Imaging: Breast Cancer Screening, Diagnosis, Staging, and Surveillance 1 Cristina Campassi, Lyn Ho, Jessica Galandak, Sergio Dromi, Divya Awal, Daniel Maver, Jasleen Chopra, and Sonya Y. Khan INTRODUCTION…
Management of High-Risk Breast Disease 2 Arielle Cimeno, Stephanie Richards, Susan B. Kesmodel, Olga Ioffe, Katherine H. R. Tkaczuk, and Emily Bellavance INTRODUCTION General Characteristics High-risk breast lesions represent…
Breast Cancer Reconstruction 8 Rachel Bluebond-Langner, Erin M. Rada, and Sheri Slezak INTRODUCTION Goals of Reconstruction Breast reconstruction is usually not a single operation but rather a process that…
Phyllodes Tumor 3 Jolinta Lin, Elizabeth Nichols, Susan B. Kesmodel, Dina Ioffe, Olga Ioffe, and Katherine H. R. Tkaczuk EPIDEMIOLOGY Phyllodes tumors (PTs) are uncommon, biphasic, fibroepithelial neoplasms of…
Breast Cancer in Pregnancy 7 Ewa Mrozek, Susan B. Kesmodel, and Katherine H. R. Tkaczuk INTRODUCTION The incidence of pregnancy-associated breast cancer (PABCa) has been increasing during the last…
Fig. 9.1 Skin resection in repeat laparotomy includes umbilicus. Incision drawing is aimed at cosmetic umbilical reconstruction 9.3.2 Examination of the Abdominal Cavity A complete abdominal lysis of adhesions is…
Fig. 4.1 p53-positive staining of small aggregates of neoplastic cells in the fimbria (IHC-P, × 50) 4.2.1 Pathology What the pathologist receives after a CRS procedure is a complex puzzle…
Fig. 6.1 Coronal contrast-enhanced computed tomography (CT) image showing (a) multiple nodules with a diameter > 5 mm diffusely involving the tunica serosa over bowel loops and paracolic gutters (arrows),…
Setting Study [Reference] No. Residual disease Survival Primary cytoreduction 5-year (%) Median (months) Hoskins (1994) [5] 41 R 0 60 62 ≤1 cm 35 77 >1 cm 20–35 Chi (2006)…